Skip to content
Newsroom
Certifications
About Us
Contact Us
Become One
Student
Individual
Fellow
Newsroom
Certifications
About Us
Contact Us
Become One
Student
Individual
Fellow
Login
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus (RSV)
Latest Posts
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%
January 22, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women
January 22, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Universal nirsevimab slashes RSV infant hospitalizations, study suggests
January 14, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Pfizer’s RSV vaccine safe to use during pregnancy, study suggests
January 11, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Studies: RSV prevention strategies—especially nirsevimab—may cut infant hospitalizations
January 3, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV confers similar risk of poor outcomes in hospitalized patients as flu over time, data suggest
January 1, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids
December 30, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest
December 18, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Recently approved RSV prevention therapies may be next FDA target
December 10, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV tied to heart problems, breathing issues well after infection in adults
December 10, 2025
Load More
× Clear
Categories
Rss
Cidrap Edu
Cna Asia
Ecdc Europa
New York Times News
Times of India
Sub-categories
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%
January 22, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women
January 22, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Universal nirsevimab slashes RSV infant hospitalizations, study suggests
January 14, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Pfizer’s RSV vaccine safe to use during pregnancy, study suggests
January 11, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Studies: RSV prevention strategies—especially nirsevimab—may cut infant hospitalizations
January 3, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV confers similar risk of poor outcomes in hospitalized patients as flu over time, data suggest
January 1, 2026
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids
December 30, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest
December 18, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Recently approved RSV prevention therapies may be next FDA target
December 10, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV tied to heart problems, breathing issues well after infection in adults
December 10, 2025
×
Download
Share to LinkedIn
